These Guidelines represent the third time that the ESC and EACTS have brought together
cardiologists and cardiac surgeons in a joint Task Force to review the ever-increasing body …

Background Dual antiplatelet therapy (DAPT) with aspirin plus a P2Y 12 inhibitor prevents
ischaemic events after coronary stenting, but increases bleeding. Guidelines support …

always refer to the full text version, which is freely available on the ESC and EACTS
websites. The National Societies of the ESC are encouraged to endorse, translate, and …

Background Patients at high risk for bleeding who undergo percutaneous coronary
intervention (PCI) often receive bare-metal stents followed by 1 month of dual antiplatelet …

Background: Complex percutaneous coronary intervention (PCI) is associated with higher
ischemic risk, which can be mitigated by long-term dual antiplatelet therapy (DAPT) …

Zachęca się pracowników opieki zdrowotnej, aby w pełni uwzględniali te wytyczne
ESC/EACTS, gdy dokonują oceny klinicznej, a także kiedy określają i realizują medyczne …

Background: Contemporary second-generation drug-eluting stents (DES) have superior
efficacy and safety in comparison with early-generation stents in patients undergoing …

Background The development of coronary drug-eluting stents has included use of new metal
alloys, changes in stent architecture, and use of bioresorbable polymers. Whether these …

Background Newer-generation drug-eluting stents that combine ultrathin strut metallic
platforms with biodegradable polymers might facilitate vascular healing and improve clinical …

Background Recent reports suggest an elevated incidence of bioresorbable vascular
scaffold (BVS) thrombosis (scaffold thrombosis [ScT]). Objectives This study investigated …